Skip to main content

Advertisement

Log in

Recurrent spontaneous ”neuroleptic malignant syndrome” in the absence of neuroleptic medication in probable dementia with Lewy bodies

  • LETTER TO THE EDITORS
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Rahkonen T, et al. (2003) Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older. J Neurol Neurosurg Psychiatry 74(6):720–724

    PubMed  Google Scholar 

  2. McKeith IG, et al. (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47(5):1113–1124

    PubMed  Google Scholar 

  3. Kornhuber J, Weller M (1994) Neuroleptic malignant syndrome. Curr Opin Neurol 7(4):353–357

    PubMed  Google Scholar 

  4. Ballard C, et al. (1998) Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer’s disease. Lancet 351 (9108):1032–1033

    Article  PubMed  Google Scholar 

  5. Minoshima S, et al. (2001) Alzheimer’s disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol 50(3):358–365

    PubMed  Google Scholar 

  6. Colloby SJ, et al. (2002) A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer’s disease using statistical parametric mapping. Eur J Nucl Med 29(5):615–622

    Article  Google Scholar 

  7. Donnemiller E, et al. (1997) Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123Ibeta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease. Eur J Nucl Med 24(3):320–325

    PubMed  Google Scholar 

  8. Kanemaru K, Kameda N, Yamanouchi H (2000) Decreased CSF amyloid beta42 and normal tau levels in dementia with Lewy bodies. Neurology 54(9):1875–1876

    PubMed  Google Scholar 

  9. Tschampa HJ, et al. (2001) Decreased CSF amyloid beta42 and normal tau levels in dementia with Lewy bodies. Neurology 56(4):576

    Google Scholar 

  10. Mizuta E, et al. (1993) Neuroleptic malignant syndrome in a parkinsonian woman during the premenstrual period. Neurology 43(5):1048–1049

    PubMed  Google Scholar 

  11. Ochi G, et al. (1995) Neuroleptic malignant- like syndrome: a complication of acute organophosphate poisoning. Can J Anaesth 42(11):1027–1030

    PubMed  Google Scholar 

  12. Konagaya M, et al. (1997) Neuroleptic malignant syndrome-like condition in multiple system atrophy. J Neurol Neurosurg Psychiatry 63(1):120–121

    Google Scholar 

  13. Hayashi K, et al. (1993) Clinical features of neuroleptic malignant syndrome in basal ganglia disease. Spontaneous presentation in a patient with Hallervorden-Spatz disease in the absence of neuroleptic drugs. Anaesthesia 48(6):499–502

    PubMed  Google Scholar 

  14. Piggott MA, et al. (1998) Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson’s disease. Biol Psychiatry 44(8):765–774

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Classen MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weber, K.E., Linker, R.A., Lorenz, R. et al. Recurrent spontaneous ”neuroleptic malignant syndrome” in the absence of neuroleptic medication in probable dementia with Lewy bodies. J Neurol 252, 1122–1124 (2005). https://doi.org/10.1007/s00415-005-0804-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-005-0804-1

Keywords

Navigation